Global Human Prothrombin Complex Concentrate Market Growth 2026-2032
The global Human Prothrombin Complex Concentrate market size is predicted to grow from US$ 1435 million in 2025 to US$ 2897 million in 2032; it is expected to grow at a CAGR of 10.8% from 2026 to 2032.
Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).In 2024, global Human prothrombin complex concentrate production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.
The global market for Human Prothrombin Complex Concentrate is primarily driven by the expansion of clinical applications for plasma-derived products, heightened awareness of severe bleeding management, and the growing need for anticoagulant reversal therapy. With an aging population and increased use of anticoagulants, demand for rapid and safe hemostatic solutions continues to rise. Increased investments in trauma care systems and perioperative bleeding management for cardiovascular and hepatic patients across various countries are expanding the market potential for PCC products. Meanwhile, advances in recombinant technology and viral inactivation processes have enhanced product safety and accessibility, further propelling global market growth.
The development of the PCC market remains constrained by the limited availability of plasma resources, the complexity of production processes, and stringent regulatory requirements. Imbalances in plasma collection systems lead to supply chain instability, while manufacturing involves multiple high-precision steps such as viral inactivation, purification, and lyophilization, requiring significant technological expertise and cost investment. Differences in regulatory approval pathways, ethical standards, and drug traceability systems across countries may further delay product commercialization. Additionally, the emergence of recombinant clotting factors and synthetic hemostatic substitutes poses potential competition in specific clinical applications, raising the bar for innovation and compliance among traditional PCC manufacturers.
Downstream demand for PCC primarily originates from hospital emergency departments, intensive care units, and surgical applications. With the increasing volume of cardiovascular interventions, hepatobiliary surgeries, and trauma procedures, clinical use of PCC continues to expand. Reversal of anticoagulant-induced bleeding, particularly from warfarin therapy, has become one of its main use cases. Moreover, PCC usage is growing steadily in emergency and perioperative coagulation management. In developing regions, accessibility to plasma-derived products is improving, leading to rising import and local production demand for PCC, alongside a diffusion trend from tertiary hospitals to regional medical institutions.
The primary upstream raw material for PCC production is high-quality human plasma, whose stable supply is essential for maintaining industry competitiveness. Plasma must undergo rigorous screening, separation, and viral inactivation processes, and instability at any stage can impact product yield and safety. Global plasma collection is concentrated among a few major suppliers, and regional regulatory variations may lead to uneven supply. In addition to plasma, the production process requires auxiliary materials such as chromatographic resins, filtration membranes, and lyoprotectants, whose purity and batch consistency are critical for quality assurance. As the industry moves toward higher purity and safety standards, manufacturers are increasingly strengthening raw material traceability and consistency management across the supply chain.
LP Information, Inc. (LPI) ' newest research report, the ?Human Prothrombin Complex Concentrate Industry Forecast? looks at past sales and reviews total world Human Prothrombin Complex Concentrate sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Prothrombin Complex Concentrate sales for 2026 through 2032. With Human Prothrombin Complex Concentrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Prothrombin Complex Concentrate industry.
This Insight Report provides a comprehensive analysis of the global Human Prothrombin Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Prothrombin Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Prothrombin Complex Concentrate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Prothrombin Complex Concentrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Prothrombin Complex Concentrate.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex Concentrate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).In 2024, global Human prothrombin complex concentrate production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.
The global market for Human Prothrombin Complex Concentrate is primarily driven by the expansion of clinical applications for plasma-derived products, heightened awareness of severe bleeding management, and the growing need for anticoagulant reversal therapy. With an aging population and increased use of anticoagulants, demand for rapid and safe hemostatic solutions continues to rise. Increased investments in trauma care systems and perioperative bleeding management for cardiovascular and hepatic patients across various countries are expanding the market potential for PCC products. Meanwhile, advances in recombinant technology and viral inactivation processes have enhanced product safety and accessibility, further propelling global market growth.
The development of the PCC market remains constrained by the limited availability of plasma resources, the complexity of production processes, and stringent regulatory requirements. Imbalances in plasma collection systems lead to supply chain instability, while manufacturing involves multiple high-precision steps such as viral inactivation, purification, and lyophilization, requiring significant technological expertise and cost investment. Differences in regulatory approval pathways, ethical standards, and drug traceability systems across countries may further delay product commercialization. Additionally, the emergence of recombinant clotting factors and synthetic hemostatic substitutes poses potential competition in specific clinical applications, raising the bar for innovation and compliance among traditional PCC manufacturers.
Downstream demand for PCC primarily originates from hospital emergency departments, intensive care units, and surgical applications. With the increasing volume of cardiovascular interventions, hepatobiliary surgeries, and trauma procedures, clinical use of PCC continues to expand. Reversal of anticoagulant-induced bleeding, particularly from warfarin therapy, has become one of its main use cases. Moreover, PCC usage is growing steadily in emergency and perioperative coagulation management. In developing regions, accessibility to plasma-derived products is improving, leading to rising import and local production demand for PCC, alongside a diffusion trend from tertiary hospitals to regional medical institutions.
The primary upstream raw material for PCC production is high-quality human plasma, whose stable supply is essential for maintaining industry competitiveness. Plasma must undergo rigorous screening, separation, and viral inactivation processes, and instability at any stage can impact product yield and safety. Global plasma collection is concentrated among a few major suppliers, and regional regulatory variations may lead to uneven supply. In addition to plasma, the production process requires auxiliary materials such as chromatographic resins, filtration membranes, and lyoprotectants, whose purity and batch consistency are critical for quality assurance. As the industry moves toward higher purity and safety standards, manufacturers are increasingly strengthening raw material traceability and consistency management across the supply chain.
LP Information, Inc. (LPI) ' newest research report, the ?Human Prothrombin Complex Concentrate Industry Forecast? looks at past sales and reviews total world Human Prothrombin Complex Concentrate sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Prothrombin Complex Concentrate sales for 2026 through 2032. With Human Prothrombin Complex Concentrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Prothrombin Complex Concentrate industry.
This Insight Report provides a comprehensive analysis of the global Human Prothrombin Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Prothrombin Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Prothrombin Complex Concentrate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Prothrombin Complex Concentrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Prothrombin Complex Concentrate.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex Concentrate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Beriplex
- Profilnine
- Octaplex
- Prothromplex
- Cofact
- Other
- 3-Factor PCC
- 4-Factor PCC
- Recombinant Coagulation Complex
- Other
- Plasma-Derived
- Recombinant Bioengineered
- Hemophilia B
- Vitamin K Deficiency
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Octapharma
- Prothya Biosolutions
- Takeda
- RAAS
- Hualan Bio
- BOHUI
- NUOYI BIO
- SINOPHARM
- Guangdong Weilun
- Weiguang Bio
- Kangbo Bio
- Huarun Boya
- Taibang Biologic
- What is the 10-year outlook for the global Human Prothrombin Complex Concentrate market?
- What factors are driving Human Prothrombin Complex Concentrate market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Human Prothrombin Complex Concentrate market opportunities vary by end market size?
- How does Human Prothrombin Complex Concentrate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Prothrombin Complex Concentrate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Prothrombin Complex Concentrate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Prothrombin Complex Concentrate by Country/Region, 2021, 2025 & 2032
2.2 Human Prothrombin Complex Concentrate Segment by Type
2.2.1 Beriplex
2.2.2 Profilnine
2.2.3 Octaplex
2.2.4 Prothromplex
2.2.5 Cofact
2.2.6 Other
2.2.7 Human Prothrombin Complex Concentrate Sales by Type
2.2.7.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
2.2.7.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Human Prothrombin Complex Concentrate Sale Price by Type (2021-2026)
2.3 Human Prothrombin Complex Concentrate Segment by Composition
2.3.1 3-Factor PCC
2.3.2 4-Factor PCC
2.3.3 Recombinant Coagulation Complex
2.3.4 Other
2.3.5 Human Prothrombin Complex Concentrate Sales by Composition
2.3.5.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Composition (2021-2026)
2.3.5.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Composition (2021-2026)
2.3.5.3 Global Human Prothrombin Complex Concentrate Sale Price by Composition (2021-2026)
2.4 Human Prothrombin Complex Concentrate Segment by Manufacturing Process
2.4.1 Plasma-Derived
2.4.2 Recombinant Bioengineered
2.4.3 Human Prothrombin Complex Concentrate Sales by Manufacturing Process
2.4.3.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process (2021-2026)
2.4.3.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Manufacturing Process (2021-2026)
2.4.3.3 Global Human Prothrombin Complex Concentrate Sale Price by Manufacturing Process (2021-2026)
2.5 Human Prothrombin Complex Concentrate Segment by Application
2.5.1 Hemophilia B
2.5.2 Vitamin K Deficiency
2.5.3 Other
2.5.4 Human Prothrombin Complex Concentrate Sales by Application
2.5.4.1 Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2021-2026)
2.5.4.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Human Prothrombin Complex Concentrate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Prothrombin Complex Concentrate Breakdown Data by Company
3.1.1 Global Human Prothrombin Complex Concentrate Annual Sales by Company (2021-2026)
3.1.2 Global Human Prothrombin Complex Concentrate Sales Market Share by Company (2021-2026)
3.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Company (2021-2026)
3.2.1 Global Human Prothrombin Complex Concentrate Revenue by Company (2021-2026)
3.2.2 Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2021-2026)
3.3 Global Human Prothrombin Complex Concentrate Sale Price by Company
3.4 Key Manufacturers Human Prothrombin Complex Concentrate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Prothrombin Complex Concentrate Product Location Distribution
3.4.2 Players Human Prothrombin Complex Concentrate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN PROTHROMBIN COMPLEX CONCENTRATE BY GEOGRAPHIC REGION
4.1 World Historic Human Prothrombin Complex Concentrate Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Prothrombin Complex Concentrate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Prothrombin Complex Concentrate Market Size by Country/Region (2021-2026)
4.2.1 Global Human Prothrombin Complex Concentrate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Prothrombin Complex Concentrate Sales Growth
4.4 APAC Human Prothrombin Complex Concentrate Sales Growth
4.5 Europe Human Prothrombin Complex Concentrate Sales Growth
4.6 Middle East & Africa Human Prothrombin Complex Concentrate Sales Growth
5 AMERICAS
5.1 Americas Human Prothrombin Complex Concentrate Sales by Country
5.1.1 Americas Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
5.1.2 Americas Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
5.2 Americas Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
5.3 Americas Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Prothrombin Complex Concentrate Sales by Region
6.1.1 APAC Human Prothrombin Complex Concentrate Sales by Region (2021-2026)
6.1.2 APAC Human Prothrombin Complex Concentrate Revenue by Region (2021-2026)
6.2 APAC Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
6.3 APAC Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Prothrombin Complex Concentrate by Country
7.1.1 Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
7.1.2 Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
7.2 Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
7.3 Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Prothrombin Complex Concentrate by Country
8.1.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
8.3 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Prothrombin Complex Concentrate
10.3 Manufacturing Process Analysis of Human Prothrombin Complex Concentrate
10.4 Industry Chain Structure of Human Prothrombin Complex Concentrate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Prothrombin Complex Concentrate Distributors
11.3 Human Prothrombin Complex Concentrate Customer
12 WORLD FORECAST REVIEW FOR HUMAN PROTHROMBIN COMPLEX CONCENTRATE BY GEOGRAPHIC REGION
12.1 Global Human Prothrombin Complex Concentrate Market Size Forecast by Region
12.1.1 Global Human Prothrombin Complex Concentrate Forecast by Region (2027-2032)
12.1.2 Global Human Prothrombin Complex Concentrate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Prothrombin Complex Concentrate Forecast by Type (2027-2032)
12.7 Global Human Prothrombin Complex Concentrate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.1.3 CSL Behring Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.2.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.3.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Prothya Biosolutions
13.4.1 Prothya Biosolutions Company Information
13.4.2 Prothya Biosolutions Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.4.3 Prothya Biosolutions Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Prothya Biosolutions Main Business Overview
13.4.5 Prothya Biosolutions Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.5.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 RAAS
13.6.1 RAAS Company Information
13.6.2 RAAS Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.6.3 RAAS Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 RAAS Main Business Overview
13.6.5 RAAS Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.7.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 BOHUI
13.8.1 BOHUI Company Information
13.8.2 BOHUI Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.8.3 BOHUI Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BOHUI Main Business Overview
13.8.5 BOHUI Latest Developments
13.9 NUOYI BIO
13.9.1 NUOYI BIO Company Information
13.9.2 NUOYI BIO Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.9.3 NUOYI BIO Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 NUOYI BIO Main Business Overview
13.9.5 NUOYI BIO Latest Developments
13.10 SINOPHARM
13.10.1 SINOPHARM Company Information
13.10.2 SINOPHARM Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.10.3 SINOPHARM Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SINOPHARM Main Business Overview
13.10.5 SINOPHARM Latest Developments
13.11 Guangdong Weilun
13.11.1 Guangdong Weilun Company Information
13.11.2 Guangdong Weilun Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.11.3 Guangdong Weilun Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Weilun Main Business Overview
13.11.5 Guangdong Weilun Latest Developments
13.12 Weiguang Bio
13.12.1 Weiguang Bio Company Information
13.12.2 Weiguang Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.12.3 Weiguang Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Weiguang Bio Main Business Overview
13.12.5 Weiguang Bio Latest Developments
13.13 Kangbo Bio
13.13.1 Kangbo Bio Company Information
13.13.2 Kangbo Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.13.3 Kangbo Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kangbo Bio Main Business Overview
13.13.5 Kangbo Bio Latest Developments
13.14 Huarun Boya
13.14.1 Huarun Boya Company Information
13.14.2 Huarun Boya Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.14.3 Huarun Boya Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Huarun Boya Main Business Overview
13.14.5 Huarun Boya Latest Developments
13.15 Taibang Biologic
13.15.1 Taibang Biologic Company Information
13.15.2 Taibang Biologic Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.15.3 Taibang Biologic Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Taibang Biologic Main Business Overview
13.15.5 Taibang Biologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Prothrombin Complex Concentrate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Prothrombin Complex Concentrate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Prothrombin Complex Concentrate by Country/Region, 2021, 2025 & 2032
2.2 Human Prothrombin Complex Concentrate Segment by Type
2.2.1 Beriplex
2.2.2 Profilnine
2.2.3 Octaplex
2.2.4 Prothromplex
2.2.5 Cofact
2.2.6 Other
2.2.7 Human Prothrombin Complex Concentrate Sales by Type
2.2.7.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
2.2.7.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Human Prothrombin Complex Concentrate Sale Price by Type (2021-2026)
2.3 Human Prothrombin Complex Concentrate Segment by Composition
2.3.1 3-Factor PCC
2.3.2 4-Factor PCC
2.3.3 Recombinant Coagulation Complex
2.3.4 Other
2.3.5 Human Prothrombin Complex Concentrate Sales by Composition
2.3.5.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Composition (2021-2026)
2.3.5.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Composition (2021-2026)
2.3.5.3 Global Human Prothrombin Complex Concentrate Sale Price by Composition (2021-2026)
2.4 Human Prothrombin Complex Concentrate Segment by Manufacturing Process
2.4.1 Plasma-Derived
2.4.2 Recombinant Bioengineered
2.4.3 Human Prothrombin Complex Concentrate Sales by Manufacturing Process
2.4.3.1 Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process (2021-2026)
2.4.3.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Manufacturing Process (2021-2026)
2.4.3.3 Global Human Prothrombin Complex Concentrate Sale Price by Manufacturing Process (2021-2026)
2.5 Human Prothrombin Complex Concentrate Segment by Application
2.5.1 Hemophilia B
2.5.2 Vitamin K Deficiency
2.5.3 Other
2.5.4 Human Prothrombin Complex Concentrate Sales by Application
2.5.4.1 Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2021-2026)
2.5.4.2 Global Human Prothrombin Complex Concentrate Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Human Prothrombin Complex Concentrate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Prothrombin Complex Concentrate Breakdown Data by Company
3.1.1 Global Human Prothrombin Complex Concentrate Annual Sales by Company (2021-2026)
3.1.2 Global Human Prothrombin Complex Concentrate Sales Market Share by Company (2021-2026)
3.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Company (2021-2026)
3.2.1 Global Human Prothrombin Complex Concentrate Revenue by Company (2021-2026)
3.2.2 Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2021-2026)
3.3 Global Human Prothrombin Complex Concentrate Sale Price by Company
3.4 Key Manufacturers Human Prothrombin Complex Concentrate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Prothrombin Complex Concentrate Product Location Distribution
3.4.2 Players Human Prothrombin Complex Concentrate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN PROTHROMBIN COMPLEX CONCENTRATE BY GEOGRAPHIC REGION
4.1 World Historic Human Prothrombin Complex Concentrate Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Prothrombin Complex Concentrate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Prothrombin Complex Concentrate Market Size by Country/Region (2021-2026)
4.2.1 Global Human Prothrombin Complex Concentrate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Prothrombin Complex Concentrate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Prothrombin Complex Concentrate Sales Growth
4.4 APAC Human Prothrombin Complex Concentrate Sales Growth
4.5 Europe Human Prothrombin Complex Concentrate Sales Growth
4.6 Middle East & Africa Human Prothrombin Complex Concentrate Sales Growth
5 AMERICAS
5.1 Americas Human Prothrombin Complex Concentrate Sales by Country
5.1.1 Americas Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
5.1.2 Americas Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
5.2 Americas Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
5.3 Americas Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Prothrombin Complex Concentrate Sales by Region
6.1.1 APAC Human Prothrombin Complex Concentrate Sales by Region (2021-2026)
6.1.2 APAC Human Prothrombin Complex Concentrate Revenue by Region (2021-2026)
6.2 APAC Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
6.3 APAC Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Prothrombin Complex Concentrate by Country
7.1.1 Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
7.1.2 Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
7.2 Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
7.3 Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Prothrombin Complex Concentrate by Country
8.1.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Prothrombin Complex Concentrate Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026)
8.3 Middle East & Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Prothrombin Complex Concentrate
10.3 Manufacturing Process Analysis of Human Prothrombin Complex Concentrate
10.4 Industry Chain Structure of Human Prothrombin Complex Concentrate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Prothrombin Complex Concentrate Distributors
11.3 Human Prothrombin Complex Concentrate Customer
12 WORLD FORECAST REVIEW FOR HUMAN PROTHROMBIN COMPLEX CONCENTRATE BY GEOGRAPHIC REGION
12.1 Global Human Prothrombin Complex Concentrate Market Size Forecast by Region
12.1.1 Global Human Prothrombin Complex Concentrate Forecast by Region (2027-2032)
12.1.2 Global Human Prothrombin Complex Concentrate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Prothrombin Complex Concentrate Forecast by Type (2027-2032)
12.7 Global Human Prothrombin Complex Concentrate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.1.3 CSL Behring Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.2.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.3.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Prothya Biosolutions
13.4.1 Prothya Biosolutions Company Information
13.4.2 Prothya Biosolutions Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.4.3 Prothya Biosolutions Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Prothya Biosolutions Main Business Overview
13.4.5 Prothya Biosolutions Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.5.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 RAAS
13.6.1 RAAS Company Information
13.6.2 RAAS Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.6.3 RAAS Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 RAAS Main Business Overview
13.6.5 RAAS Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.7.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 BOHUI
13.8.1 BOHUI Company Information
13.8.2 BOHUI Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.8.3 BOHUI Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BOHUI Main Business Overview
13.8.5 BOHUI Latest Developments
13.9 NUOYI BIO
13.9.1 NUOYI BIO Company Information
13.9.2 NUOYI BIO Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.9.3 NUOYI BIO Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 NUOYI BIO Main Business Overview
13.9.5 NUOYI BIO Latest Developments
13.10 SINOPHARM
13.10.1 SINOPHARM Company Information
13.10.2 SINOPHARM Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.10.3 SINOPHARM Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SINOPHARM Main Business Overview
13.10.5 SINOPHARM Latest Developments
13.11 Guangdong Weilun
13.11.1 Guangdong Weilun Company Information
13.11.2 Guangdong Weilun Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.11.3 Guangdong Weilun Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Weilun Main Business Overview
13.11.5 Guangdong Weilun Latest Developments
13.12 Weiguang Bio
13.12.1 Weiguang Bio Company Information
13.12.2 Weiguang Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.12.3 Weiguang Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Weiguang Bio Main Business Overview
13.12.5 Weiguang Bio Latest Developments
13.13 Kangbo Bio
13.13.1 Kangbo Bio Company Information
13.13.2 Kangbo Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.13.3 Kangbo Bio Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Kangbo Bio Main Business Overview
13.13.5 Kangbo Bio Latest Developments
13.14 Huarun Boya
13.14.1 Huarun Boya Company Information
13.14.2 Huarun Boya Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.14.3 Huarun Boya Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Huarun Boya Main Business Overview
13.14.5 Huarun Boya Latest Developments
13.15 Taibang Biologic
13.15.1 Taibang Biologic Company Information
13.15.2 Taibang Biologic Human Prothrombin Complex Concentrate Product Portfolios and Specifications
13.15.3 Taibang Biologic Human Prothrombin Complex Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Taibang Biologic Main Business Overview
13.15.5 Taibang Biologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Prothrombin Complex Concentrate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Prothrombin Complex Concentrate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Beriplex
Table 4. Major Players of Profilnine
Table 5. Major Players of Octaplex
Table 6. Major Players of Prothromplex
Table 7. Major Players of Cofact
Table 8. Major Players of Other
Table 9. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 10. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Table 11. Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2026) & ($ million)
Table 12. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026)
Table 13. Global Human Prothrombin Complex Concentrate Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of 3-Factor PCC
Table 15. Major Players of 4-Factor PCC
Table 16. Major Players of Recombinant Coagulation Complex
Table 17. Major Players of Other
Table 18. Global Human Prothrombin Complex Concentrate Sales by Composition (2021-2026) & (K Units)
Table 19. Global Human Prothrombin Complex Concentrate Sales Market Share by Composition (2021-2026)
Table 20. Global Human Prothrombin Complex Concentrate Revenue by Composition (2021-2026) & ($ million)
Table 21. Global Human Prothrombin Complex Concentrate Revenue Market Share by Composition (2021-2026)
Table 22. Global Human Prothrombin Complex Concentrate Sale Price by Composition (2021-2026) & (US$/Unit)
Table 23. Major Players of Plasma-Derived
Table 24. Major Players of Recombinant Bioengineered
Table 25. Global Human Prothrombin Complex Concentrate Sales by Manufacturing Process (2021-2026) & (K Units)
Table 26. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process (2021-2026)
Table 27. Global Human Prothrombin Complex Concentrate Revenue by Manufacturing Process (2021-2026) & ($ million)
Table 28. Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturing Process (2021-2026)
Table 29. Global Human Prothrombin Complex Concentrate Sale Price by Manufacturing Process (2021-2026) & (US$/Unit)
Table 30. Global Human Prothrombin Complex Concentrate Sale by Application (2021-2026) & (K Units)
Table 31. Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2021-2026)
Table 32. Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2026) & ($ million)
Table 33. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2026)
Table 34. Global Human Prothrombin Complex Concentrate Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Human Prothrombin Complex Concentrate Sales by Company (2021-2026) & (K Units)
Table 36. Global Human Prothrombin Complex Concentrate Sales Market Share by Company (2021-2026)
Table 37. Global Human Prothrombin Complex Concentrate Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2021-2026)
Table 39. Global Human Prothrombin Complex Concentrate Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Human Prothrombin Complex Concentrate Producing Area Distribution and Sales Area
Table 41. Players Human Prothrombin Complex Concentrate Products Offered
Table 42. Human Prothrombin Complex Concentrate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Human Prothrombin Complex Concentrate Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Human Prothrombin Complex Concentrate Sales Market Share Geographic Region (2021-2026)
Table 47. Global Human Prothrombin Complex Concentrate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Human Prothrombin Complex Concentrate Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Human Prothrombin Complex Concentrate Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2021-2026)
Table 51. Global Human Prothrombin Complex Concentrate Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Human Prothrombin Complex Concentrate Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 54. Americas Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026)
Table 55. Americas Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 57. Americas Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 58. APAC Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (K Units)
Table 59. APAC Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2026)
Table 60. APAC Human Prothrombin Complex Concentrate Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 62. APAC Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 63. Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 64. Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 66. Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Human Prothrombin Complex Concentrate
Table 72. Key Market Challenges & Risks of Human Prothrombin Complex Concentrate
Table 73. Key Industry Trends of Human Prothrombin Complex Concentrate
Table 74. Human Prothrombin Complex Concentrate Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Human Prothrombin Complex Concentrate Distributors List
Table 77. Human Prothrombin Complex Concentrate Customer List
Table 78. Global Human Prothrombin Complex Concentrate Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Human Prothrombin Complex Concentrate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Human Prothrombin Complex Concentrate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Human Prothrombin Complex Concentrate Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Human Prothrombin Complex Concentrate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Human Prothrombin Complex Concentrate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Human Prothrombin Complex Concentrate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Human Prothrombin Complex Concentrate Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Human Prothrombin Complex Concentrate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Human Prothrombin Complex Concentrate Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Human Prothrombin Complex Concentrate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. CSL Behring Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Behring Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 94. CSL Behring Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CSL Behring Main Business
Table 96. CSL Behring Latest Developments
Table 97. Grifols Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 99. Grifols Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. Octapharma Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 103. Octapharma Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 104. Octapharma Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Octapharma Main Business
Table 106. Octapharma Latest Developments
Table 107. Prothya Biosolutions Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 108. Prothya Biosolutions Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 109. Prothya Biosolutions Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Prothya Biosolutions Main Business
Table 111. Prothya Biosolutions Latest Developments
Table 112. Takeda Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 113. Takeda Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 114. Takeda Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Takeda Main Business
Table 116. Takeda Latest Developments
Table 117. RAAS Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 118. RAAS Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 119. RAAS Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. RAAS Main Business
Table 121. RAAS Latest Developments
Table 122. Hualan Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 123. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 124. Hualan Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Hualan Bio Main Business
Table 126. Hualan Bio Latest Developments
Table 127. BOHUI Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 128. BOHUI Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 129. BOHUI Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. BOHUI Main Business
Table 131. BOHUI Latest Developments
Table 132. NUOYI BIO Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 133. NUOYI BIO Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 134. NUOYI BIO Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. NUOYI BIO Main Business
Table 136. NUOYI BIO Latest Developments
Table 137. SINOPHARM Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 138. SINOPHARM Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 139. SINOPHARM Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. SINOPHARM Main Business
Table 141. SINOPHARM Latest Developments
Table 142. Guangdong Weilun Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 143. Guangdong Weilun Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 144. Guangdong Weilun Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Guangdong Weilun Main Business
Table 146. Guangdong Weilun Latest Developments
Table 147. Weiguang Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 148. Weiguang Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 149. Weiguang Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Weiguang Bio Main Business
Table 151. Weiguang Bio Latest Developments
Table 152. Kangbo Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 153. Kangbo Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 154. Kangbo Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Kangbo Bio Main Business
Table 156. Kangbo Bio Latest Developments
Table 157. Huarun Boya Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 158. Huarun Boya Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 159. Huarun Boya Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Huarun Boya Main Business
Table 161. Huarun Boya Latest Developments
Table 162. Taibang Biologic Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 163. Taibang Biologic Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 164. Taibang Biologic Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Taibang Biologic Main Business
Table 166. Taibang Biologic Latest Developments
Table 1. Human Prothrombin Complex Concentrate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Prothrombin Complex Concentrate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Beriplex
Table 4. Major Players of Profilnine
Table 5. Major Players of Octaplex
Table 6. Major Players of Prothromplex
Table 7. Major Players of Cofact
Table 8. Major Players of Other
Table 9. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 10. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Table 11. Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2026) & ($ million)
Table 12. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026)
Table 13. Global Human Prothrombin Complex Concentrate Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of 3-Factor PCC
Table 15. Major Players of 4-Factor PCC
Table 16. Major Players of Recombinant Coagulation Complex
Table 17. Major Players of Other
Table 18. Global Human Prothrombin Complex Concentrate Sales by Composition (2021-2026) & (K Units)
Table 19. Global Human Prothrombin Complex Concentrate Sales Market Share by Composition (2021-2026)
Table 20. Global Human Prothrombin Complex Concentrate Revenue by Composition (2021-2026) & ($ million)
Table 21. Global Human Prothrombin Complex Concentrate Revenue Market Share by Composition (2021-2026)
Table 22. Global Human Prothrombin Complex Concentrate Sale Price by Composition (2021-2026) & (US$/Unit)
Table 23. Major Players of Plasma-Derived
Table 24. Major Players of Recombinant Bioengineered
Table 25. Global Human Prothrombin Complex Concentrate Sales by Manufacturing Process (2021-2026) & (K Units)
Table 26. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process (2021-2026)
Table 27. Global Human Prothrombin Complex Concentrate Revenue by Manufacturing Process (2021-2026) & ($ million)
Table 28. Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturing Process (2021-2026)
Table 29. Global Human Prothrombin Complex Concentrate Sale Price by Manufacturing Process (2021-2026) & (US$/Unit)
Table 30. Global Human Prothrombin Complex Concentrate Sale by Application (2021-2026) & (K Units)
Table 31. Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2021-2026)
Table 32. Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2026) & ($ million)
Table 33. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2026)
Table 34. Global Human Prothrombin Complex Concentrate Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Human Prothrombin Complex Concentrate Sales by Company (2021-2026) & (K Units)
Table 36. Global Human Prothrombin Complex Concentrate Sales Market Share by Company (2021-2026)
Table 37. Global Human Prothrombin Complex Concentrate Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2021-2026)
Table 39. Global Human Prothrombin Complex Concentrate Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Human Prothrombin Complex Concentrate Producing Area Distribution and Sales Area
Table 41. Players Human Prothrombin Complex Concentrate Products Offered
Table 42. Human Prothrombin Complex Concentrate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Human Prothrombin Complex Concentrate Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Human Prothrombin Complex Concentrate Sales Market Share Geographic Region (2021-2026)
Table 47. Global Human Prothrombin Complex Concentrate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Human Prothrombin Complex Concentrate Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Human Prothrombin Complex Concentrate Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2021-2026)
Table 51. Global Human Prothrombin Complex Concentrate Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Human Prothrombin Complex Concentrate Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 54. Americas Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026)
Table 55. Americas Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 57. Americas Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 58. APAC Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (K Units)
Table 59. APAC Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2026)
Table 60. APAC Human Prothrombin Complex Concentrate Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 62. APAC Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 63. Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 64. Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 66. Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Human Prothrombin Complex Concentrate
Table 72. Key Market Challenges & Risks of Human Prothrombin Complex Concentrate
Table 73. Key Industry Trends of Human Prothrombin Complex Concentrate
Table 74. Human Prothrombin Complex Concentrate Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Human Prothrombin Complex Concentrate Distributors List
Table 77. Human Prothrombin Complex Concentrate Customer List
Table 78. Global Human Prothrombin Complex Concentrate Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Human Prothrombin Complex Concentrate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Human Prothrombin Complex Concentrate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Human Prothrombin Complex Concentrate Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Human Prothrombin Complex Concentrate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Human Prothrombin Complex Concentrate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Human Prothrombin Complex Concentrate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Human Prothrombin Complex Concentrate Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Human Prothrombin Complex Concentrate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Human Prothrombin Complex Concentrate Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Human Prothrombin Complex Concentrate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. CSL Behring Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Behring Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 94. CSL Behring Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CSL Behring Main Business
Table 96. CSL Behring Latest Developments
Table 97. Grifols Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 99. Grifols Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. Octapharma Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 103. Octapharma Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 104. Octapharma Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Octapharma Main Business
Table 106. Octapharma Latest Developments
Table 107. Prothya Biosolutions Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 108. Prothya Biosolutions Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 109. Prothya Biosolutions Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Prothya Biosolutions Main Business
Table 111. Prothya Biosolutions Latest Developments
Table 112. Takeda Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 113. Takeda Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 114. Takeda Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Takeda Main Business
Table 116. Takeda Latest Developments
Table 117. RAAS Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 118. RAAS Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 119. RAAS Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. RAAS Main Business
Table 121. RAAS Latest Developments
Table 122. Hualan Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 123. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 124. Hualan Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Hualan Bio Main Business
Table 126. Hualan Bio Latest Developments
Table 127. BOHUI Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 128. BOHUI Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 129. BOHUI Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. BOHUI Main Business
Table 131. BOHUI Latest Developments
Table 132. NUOYI BIO Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 133. NUOYI BIO Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 134. NUOYI BIO Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. NUOYI BIO Main Business
Table 136. NUOYI BIO Latest Developments
Table 137. SINOPHARM Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 138. SINOPHARM Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 139. SINOPHARM Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. SINOPHARM Main Business
Table 141. SINOPHARM Latest Developments
Table 142. Guangdong Weilun Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 143. Guangdong Weilun Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 144. Guangdong Weilun Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Guangdong Weilun Main Business
Table 146. Guangdong Weilun Latest Developments
Table 147. Weiguang Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 148. Weiguang Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 149. Weiguang Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Weiguang Bio Main Business
Table 151. Weiguang Bio Latest Developments
Table 152. Kangbo Bio Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 153. Kangbo Bio Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 154. Kangbo Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Kangbo Bio Main Business
Table 156. Kangbo Bio Latest Developments
Table 157. Huarun Boya Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 158. Huarun Boya Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 159. Huarun Boya Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Huarun Boya Main Business
Table 161. Huarun Boya Latest Developments
Table 162. Taibang Biologic Basic Information, Human Prothrombin Complex Concentrate Manufacturing Base, Sales Area and Its Competitors
Table 163. Taibang Biologic Human Prothrombin Complex Concentrate Product Portfolios and Specifications
Table 164. Taibang Biologic Human Prothrombin Complex Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Taibang Biologic Main Business
Table 166. Taibang Biologic Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Prothrombin Complex Concentrate
Figure 2. Human Prothrombin Complex Concentrate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Prothrombin Complex Concentrate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Prothrombin Complex Concentrate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Prothrombin Complex Concentrate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2025)
Figure 10. Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Beriplex
Figure 12. Product Picture of Profilnine
Figure 13. Product Picture of Octaplex
Figure 14. Product Picture of Prothromplex
Figure 15. Product Picture of Cofact
Figure 16. Product Picture of Other
Figure 17. Global Human Prothrombin Complex Concentrate Sales Market Share by Type in 2026
Figure 18. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of 3-Factor PCC
Figure 20. Product Picture of 4-Factor PCC
Figure 21. Product Picture of Recombinant Coagulation Complex
Figure 22. Product Picture of Other
Figure 23. Global Human Prothrombin Complex Concentrate Sales Market Share by Composition in 2026
Figure 24. Global Human Prothrombin Complex Concentrate Revenue Market Share by Composition (2021-2026)
Figure 25. Product Picture of Plasma-Derived
Figure 26. Product Picture of Recombinant Bioengineered
Figure 27. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process in 2026
Figure 28. Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturing Process (2021-2026)
Figure 29. Human Prothrombin Complex Concentrate Consumed in Hemophilia B
Figure 30. Global Human Prothrombin Complex Concentrate Market: Hemophilia B (2021-2026) & (K Units)
Figure 31. Human Prothrombin Complex Concentrate Consumed in Vitamin K Deficiency
Figure 32. Global Human Prothrombin Complex Concentrate Market: Vitamin K Deficiency (2021-2026) & (K Units)
Figure 33. Human Prothrombin Complex Concentrate Consumed in Other
Figure 34. Global Human Prothrombin Complex Concentrate Market: Other (2021-2026) & (K Units)
Figure 35. Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2025)
Figure 36. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application in 2026
Figure 37. Human Prothrombin Complex Concentrate Sales by Company in 2026 (K Units)
Figure 38. Global Human Prothrombin Complex Concentrate Sales Market Share by Company in 2026
Figure 39. Human Prothrombin Complex Concentrate Revenue by Company in 2026 ($ millions)
Figure 40. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company in 2026
Figure 41. Global Human Prothrombin Complex Concentrate Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Human Prothrombin Complex Concentrate Revenue Market Share by Geographic Region in 2026
Figure 43. Americas Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 44. Americas Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 45. APAC Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 46. APAC Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 47. Europe Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 48. Europe Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 50. Middle East & Africa Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 51. Americas Human Prothrombin Complex Concentrate Sales Market Share by Country in 2026
Figure 52. Americas Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Figure 53. Americas Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 54. Americas Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 55. United States Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Human Prothrombin Complex Concentrate Sales Market Share by Region in 2026
Figure 60. APAC Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2026)
Figure 61. APAC Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 62. APAC Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 63. China Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 67. India Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Human Prothrombin Complex Concentrate Sales Market Share by Country in 2026
Figure 71. Europe Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Figure 72. Europe Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 73. Europe Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 74. Germany Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 75. France Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 82. Egypt Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Human Prothrombin Complex Concentrate in 2026
Figure 88. Manufacturing Process Analysis of Human Prothrombin Complex Concentrate
Figure 89. Industry Chain Structure of Human Prothrombin Complex Concentrate
Figure 90. Channels of Distribution
Figure 91. Global Human Prothrombin Complex Concentrate Sales Market Forecast by Region (2027-2032)
Figure 92. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Human Prothrombin Complex Concentrate Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Human Prothrombin Complex Concentrate Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Human Prothrombin Complex Concentrate
Figure 2. Human Prothrombin Complex Concentrate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Prothrombin Complex Concentrate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Prothrombin Complex Concentrate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Prothrombin Complex Concentrate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2025)
Figure 10. Human Prothrombin Complex Concentrate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Beriplex
Figure 12. Product Picture of Profilnine
Figure 13. Product Picture of Octaplex
Figure 14. Product Picture of Prothromplex
Figure 15. Product Picture of Cofact
Figure 16. Product Picture of Other
Figure 17. Global Human Prothrombin Complex Concentrate Sales Market Share by Type in 2026
Figure 18. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of 3-Factor PCC
Figure 20. Product Picture of 4-Factor PCC
Figure 21. Product Picture of Recombinant Coagulation Complex
Figure 22. Product Picture of Other
Figure 23. Global Human Prothrombin Complex Concentrate Sales Market Share by Composition in 2026
Figure 24. Global Human Prothrombin Complex Concentrate Revenue Market Share by Composition (2021-2026)
Figure 25. Product Picture of Plasma-Derived
Figure 26. Product Picture of Recombinant Bioengineered
Figure 27. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturing Process in 2026
Figure 28. Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturing Process (2021-2026)
Figure 29. Human Prothrombin Complex Concentrate Consumed in Hemophilia B
Figure 30. Global Human Prothrombin Complex Concentrate Market: Hemophilia B (2021-2026) & (K Units)
Figure 31. Human Prothrombin Complex Concentrate Consumed in Vitamin K Deficiency
Figure 32. Global Human Prothrombin Complex Concentrate Market: Vitamin K Deficiency (2021-2026) & (K Units)
Figure 33. Human Prothrombin Complex Concentrate Consumed in Other
Figure 34. Global Human Prothrombin Complex Concentrate Market: Other (2021-2026) & (K Units)
Figure 35. Global Human Prothrombin Complex Concentrate Sale Market Share by Application (2025)
Figure 36. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application in 2026
Figure 37. Human Prothrombin Complex Concentrate Sales by Company in 2026 (K Units)
Figure 38. Global Human Prothrombin Complex Concentrate Sales Market Share by Company in 2026
Figure 39. Human Prothrombin Complex Concentrate Revenue by Company in 2026 ($ millions)
Figure 40. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company in 2026
Figure 41. Global Human Prothrombin Complex Concentrate Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Human Prothrombin Complex Concentrate Revenue Market Share by Geographic Region in 2026
Figure 43. Americas Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 44. Americas Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 45. APAC Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 46. APAC Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 47. Europe Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 48. Europe Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Prothrombin Complex Concentrate Sales 2021-2026 (K Units)
Figure 50. Middle East & Africa Human Prothrombin Complex Concentrate Revenue 2021-2026 ($ millions)
Figure 51. Americas Human Prothrombin Complex Concentrate Sales Market Share by Country in 2026
Figure 52. Americas Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Figure 53. Americas Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 54. Americas Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 55. United States Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Human Prothrombin Complex Concentrate Sales Market Share by Region in 2026
Figure 60. APAC Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2026)
Figure 61. APAC Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 62. APAC Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 63. China Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 67. India Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Human Prothrombin Complex Concentrate Sales Market Share by Country in 2026
Figure 71. Europe Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2026)
Figure 72. Europe Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 73. Europe Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 74. Germany Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 75. France Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026)
Figure 82. Egypt Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Human Prothrombin Complex Concentrate Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Human Prothrombin Complex Concentrate in 2026
Figure 88. Manufacturing Process Analysis of Human Prothrombin Complex Concentrate
Figure 89. Industry Chain Structure of Human Prothrombin Complex Concentrate
Figure 90. Channels of Distribution
Figure 91. Global Human Prothrombin Complex Concentrate Sales Market Forecast by Region (2027-2032)
Figure 92. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Human Prothrombin Complex Concentrate Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Human Prothrombin Complex Concentrate Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Human Prothrombin Complex Concentrate Revenue Market Share Forecast by Application (2027-2032)
